Core Laboratories N.V.
CLB · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $32 | $37 | $20 | $20 |
| Dep. & Amort. | $15 | $16 | $17 | $19 |
| Deferred Tax | $1 | -$11 | $0 | $6 |
| Stock-Based Comp. | $4 | $14 | $8 | $19 |
| Change in WC | $8 | -$29 | -$25 | -$24 |
| Other Non-Cash | -$3 | -$2 | $5 | -$3 |
| Operating Cash Flow | $56 | $25 | $25 | $37 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$13 | -$11 | -$10 | -$14 |
| Net Acquisitions | $0 | $0 | $0 | $1 |
| Inv. Purchases | $0 | $0 | $0 | $14 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $1 |
| Other Inv. Act. | $7 | $4 | $6 | -$12 |
| Investing Cash Flow | -$6 | -$7 | -$4 | -$10 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$38 | -$9 | -$15 | -$71 |
| Stock Issued | $0 | $0 | $0 | $60 |
| Stock Repurch. | -$5 | -$2 | -$4 | -$8 |
| Dividends Paid | -$2 | -$2 | -$2 | -$2 |
| Other Fin. Act. | -$1 | -$5 | -$3 | -$1 |
| Financing Cash Flow | -$46 | -$18 | -$23 | -$22 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $4 | -$0 | -$2 | $4 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $15 | $15 | $18 | $14 |
| End Cash | $19 | $15 | $15 | $18 |
| Free Cash Flow | $43 | $14 | $15 | $23 |